Extracted from this filing and checked against the source text.
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
NeueHealth, Inc. completed a disposition involving Molina Healthcare, Inc. for $500.0 million in cash (closed 2024-01-01).
- Action
- disposition
- Counterparty
- Molina Healthcare, Inc.
- Consideration
- $500.0 million in cash
- Closing
- 2024-01-01
Exact text from the filing
pursuant to which, among other things, BHCC agreed to sell to Molina all of its shares of capital stock in CHP and BND (together, the “ MA Business ”) for an aggregate purchase price of $500.0 million in cash, subject to certain purchase price adjustments (such sale, the “ Transaction ”), and, following the consummation of the Transaction, each of BND and CHP would be a wholly owned subsidiary of Molina. Effective as of January 1, 2024, the Transaction was consummated.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
NeueHealth, Inc. terminated Credit Agreement dated as of March 1, 2021 with JPMorgan Chase Bank, N.A. and the Lenders valued at Payoff of $274.6 million and cash collateral of $24.1 million (effective 2024-01-02).
- Action
- termination
- Agreement
- credit facility
- Counterparty
- JPMorgan Chase Bank, N.A. and the Lenders
- Value
- Payoff of $274.6 million and cash collateral of $24.1 million
- Effective
- 2024-01-02
Exact text from the filing
On January 2, 2024, both the Payoff Condition and the L/C Condition were satisfied and, as a result, the Consent and the Termination occurred.
View on SEC.gov